Stakeholder perspectives regarding pragmatic clinical trial collateral findings.

Stephanie R MorainDebra J H MathewsKevin WeinfurtElizabeth MayJuli M BollingerGail GellerJeremy Sugarman

Published in: Learning health systems (2020)

PCT-CFs are likely to increase, yet those charged with PCT-CF decision-making and their disclosure are unlikely to have experience with these issues. Further deliberation about the ethical obligations and implementation processes regarding PCT-CFs is needed. To enhance the likelihood of developing sound policies and practices, such deliberations should include the input and perspectives of key stakeholders in PCTs, including professionals, policy makers, and patients.

Keyphrases

healthcare
decision making
clinical trial
end stage renal disease
public health
primary care
newly diagnosed
ejection fraction
chronic kidney disease
study protocol
cystic fibrosis
peritoneal dialysis
prognostic factors
randomized controlled trial
mental health
open label
patient reported outcomes